You searched for COVID-19 - Page 15 of 16

Regenerative medicine recommended reads including $191 million to researcher

March 8, 2020 / Professor Paul Knoepfler, Ph.D. / 4 Comments

Mark-Pennesi-CRISPR-regenerative-medicine-eye

It’s notable how the FDA now considers gene-editing a kind of regenerative medicine. This means that various gene therapy products in development technically qualify as regenerative therapies. Ever since the agency began its rapidly growing regenerative medicine advanced therapy (RMAT) designation program, we’ve seen an increasing number of gene therapy biotechs and products qualify as […]

Regenerative medicine recommended reads including $191 million to researcher Read More »

Updated FDA granted RMAT List (85)

January 10, 2018 / Professor Paul Knoepfler, Ph.D.

Today’s post includes a list of firms/products that have self-reported that they have received FDA regenerative medicine advanced therapy designation or RMAT. Sometimes people call these “r mat” with a space. As of December 12, 2023 there are 85 RMATs in the public domain. I also include FDA data on RMAT submissions via an FDA RMAT resource

Updated FDA granted RMAT List (85) Read More »

If you’ve had a stem cell treatment, how was your experience?

April 24, 2016 / Professor Paul Knoepfler, Ph.D. / 473 Comments

Have you had a stem cell treatment and if so, what was your experience like? Please also see our 2020 guide and polls on stem cell treatment cost. I really value the diversity of readers on this blog from all over the world. I know we have a lot of readers who are patients and have had

If you’ve had a stem cell treatment, how was your experience? Read More »

ISSCR President Sean Morrison on challenges and future of stem cell field

August 31, 2015 / Professor Paul Knoepfler, Ph.D. / 2 Comments

I recently chatted with Sean Morrison, current President of ISSCR, on his goals for the Society, where the stem cell field stands today, top challenges, and the future. 2020 update: read my new interview with Sean on cell therapies for COVID-19. What are your goals for your tenure as President of ISSCR? SM: ISSCR is the

ISSCR President Sean Morrison on challenges and future of stem cell field Read More »

Cell Surgical Network Series Part 3: Key Concerns

November 26, 2013 / Professor Paul Knoepfler, Ph.D. / 5 Comments

I recently interviewed Drs. Elliot Lander and Mark Berman of the Cell Surgical Network. It’s an affiliated chain of clinics selling stem cell interventions for more than a dozen medical conditions. You can read Part 1 here and Part 2 here of the interview where we cover 10 important questions. Today is Part 3, where I explain why their answers

Cell Surgical Network Series Part 3: Key Concerns Read More »

Jeong Chan Ra Arrest: Can RNL Bio (알앤엘바이오) Survive?

July 13, 2013 / Professor Paul Knoepfler, Ph.D. / 4 Comments

Over at Health in the Global Village, Leigh Turner yesterday published an excellent piece updating us all on the latest news on Korean stem cell company RNL BIo (알앤엘바이오) and its leader, Dr. Jeong Chan Ra (라정찬 ). Addition: The story was reported in several Korean news outlets including Hani here. A video here by MBC News of Korea, one

Jeong Chan Ra Arrest: Can RNL Bio (알앤엘바이오) Survive? Read More »

Celltex advocate Rick Perry will not run again for Texas governor: stem cell impact

July 10, 2013 / Professor Paul Knoepfler, Ph.D. / 4 Comments

Texas Governor Rick Perry just announced that he will not run again for governor. This political development has important impact in the stem cell field, particularly in the state of Texas. Perry is one of the biggest advocates of certain types of adult stem cell commercialization. When he is no longer governor there will be impact

Celltex advocate Rick Perry will not run again for Texas governor: stem cell impact Read More »

Taboo topics about iPS cells: updated for 2013

January 11, 2013 / Professor Paul Knoepfler, Ph.D.

elephant-in-the-lab-covid-19-lab-ramp-up

I’m doing this series called “The Elephant in the Lab” where I discuss controversial or taboo laboratory topics that people are usually too afraid to publicly discuss. I started with iPS cells (for a description and definition of iPS cells go here) and now have updated this post for 2013 because the field is changing rapidly. iPS

Taboo topics about iPS cells: updated for 2013 Read More »

Did Celltex just get an FDA warning letter?

October 1, 2012 / Professor Paul Knoepfler, Ph.D. / 4 Comments

Did Celltex just get an FDA warning letter? I’m not sure. We may find out tomorrow as the FDA updates their public warning letter list early in the week. What’s Celltex? Celltex is that famous stem cell company in Sugarland, Texas that gave Guv Rick Perry stem cell transplants. It was inspected by the FDA

Did Celltex just get an FDA warning letter? Read More »

Emma Stone dishes on spiderman and stem cells: very cool!

June 27, 2012 / Professor Paul Knoepfler, Ph.D. / 3 Comments

The upcoming movie The Amazing Spider-Man with Emma Stone looks to be pretty cool and I’m not even a fan of Spider-Man. However, making me even more interested in it are the rumors that stem cells are part of the plot. Some folks view stem cells as superheroes able to cure almost anything including COVID-19, but

Emma Stone dishes on spiderman and stem cells: very cool! Read More »

Search Results for: COVID-19